GA + MGD meet FDA

20/03/2023 48 min Temporada 1 Episodio 240
GA + MGD meet FDA

Listen "GA + MGD meet FDA"

Episode Synopsis

Do you struggle when training eye care professionals in your office? Need to know where to turn for help? Join this week's hosts, Jimmy and Roya, as they share tips on training their staff and the programs and training modules available. Hear about the recent FDA approval of Syfovre, the first treatment for geographic atrophy, a leading cause of blindness worldwide. In addition, they discuss the new and different treatment options for MGD. Have an idea for a topic you would like to hear more about, or would you like to nominate or be a guest on Try Not 2 Blink? We want to hear from you! Click here to send in a suggestion, or email us at [email protected] Training ProgramParaoptometric CertificationSyfovre is AMGDpprovedPipeline Treatment for GATP-03 for TarsusNOV03 for DED+MGDAZR-MD-001 for MGDTry Not to Blink Podcast  is powered by Valley Contax